Margaret Olinger, Chief Commercial Officer at Amylyx Pharmaceuticals, Inc. (AMLX), bought 35,175 shares at $19.00 ($130K) on 2022-01-06, disclosed to the SEC on 2022-01-10.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 28,333 | $0 | 0.0% |
| 2 | $19.00 | 6,842 | $130K | 100.0% |
| Total | $3.70 avg | 35,175 | $130K | 100% |